These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3643679)

  • 21. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.
    Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA
    Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group.
    Dietrich SL; Mosley JW; Lusher JM; Hilgartner MW; Operskalski EA; Habel L; Aledort LM; Gjerset GF; Koerper MA; Lewis BH
    Vox Sang; 1990; 59(3):129-35. PubMed ID: 2124751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viral inactivation of antihemophilic factors in acquired immunodeficiency syndrome (AIDS)].
    Liras A
    Sangre (Barc); 1988 Feb; 33(1):34-8. PubMed ID: 3132744
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
    Berting A; Modrof J; Unger U; Gessner M; Klotz A; Poelsler G; Kreil TR
    Transfusion; 2008 Jun; 48(6):1220-6. PubMed ID: 18410254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.
    Cicardi M; Mannucci PM; Castelli R; Rumi MG; Agostoni A
    Transfusion; 1995 Mar; 35(3):209-12. PubMed ID: 7878712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.
    Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH
    Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lyophilised plasma: evaluation of clotting factor activity over 6 days after reconstitution for transfusion.
    Schoenfeld H; Pruss A; Keller M; Schuster M; Meinck K; Neuner B; von Heymann C
    J Clin Pathol; 2010 Aug; 63(8):726-30. PubMed ID: 20702474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of heat inactivation of HIV on specific serum proteins and tumour markers.
    Gleeson M; Herd L; Burns C
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():592-4. PubMed ID: 2080860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral safety of solvent-detergent treated blood products.
    Horowitz B; Prince AM; Horowitz MS; Watklevicz C
    Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.
    Prikhod'ko GG; Vasilyeva I; Reyes H; Wong S; Brown KE; Jameson T; Busby TF
    Transfusion; 2005 Jun; 45(6):1011-9. PubMed ID: 15935001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.
    McDougal JS; Martin LS; Cort SP; Mozen M; Heldebrant CM; Evatt BL
    J Clin Invest; 1985 Aug; 76(2):875-7. PubMed ID: 2993366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The problem of obtaining virus-free blood products].
    Péter S; Schnitzer F
    Orv Hetil; 1994 Mar; 135(11):601. PubMed ID: 8159414
    [No Abstract]   [Full Text] [Related]  

  • 36. Inactivation of AIDS-causing retroviruses by the manufacturing procedures for human plasma proteins.
    Hilfenhaus J; Gregersen JP
    Behring Inst Mitt; 1988 Apr; (82):82-93. PubMed ID: 3044347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of stable lyophilized cryoprecipitate in the original frozen plasma bags.
    Margolis J; Eisen M
    Vox Sang; 1986; 50(1):38-41. PubMed ID: 3082076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins.
    Kitchen AD; Mann GF; Harrison JF; Zuckerman AJ
    Vox Sang; 1989; 56(4):223-9. PubMed ID: 2763500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the AIDS-causing retrovirus and other human viruses in antihemophilic plasma protein preparations by pasteurization.
    Hilfenhaus J; Herrmann A; Mauler R; Prince AM
    Vox Sang; 1986; 50(4):208-11. PubMed ID: 3014743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of human immunodeficiency virus from peripheral blood lymphocytes stored in various transport media and frozen at -60 degrees C.
    Gallo D; Kimpton JS; Johnson PJ
    J Clin Microbiol; 1989 Jan; 27(1):88-90. PubMed ID: 2913040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.